PURIXAN (Nova Laboratories, Ltd)
Welcome to the PulseAid listing for the PURIXAN drug offered from Nova Laboratories, Ltd. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Nova Laboratories, Ltd |
| NON-PROPRIETARY NAME: | Purixan |
| SUBSTANCE NAME: | MERCAPTOPURINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SUSPENSION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-04-28 |
| END MARKETING DATE: | 0000-00-00 |
PURIXAN HUMAN PRESCRIPTION DRUG Details:
| Item Description | PURIXAN from Nova Laboratories, Ltd |
| LABELER NAME: | Nova Laboratories, Ltd |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2014-04-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62484-0020_1fd9fb6c-86c3-49aa-87fb-d3ad3560e3af |
| PRODUCT NDC: | 62484-0020 |
| APPLICATION NUMBER: | NDA205919 |
Other MERCAPTOPURINE Pharmaceutical Manufacturers / Labelers:
